[ad_1]
Clinical trials for the coronavirus vaccine have been resumed by AstraZeneca and the University of Oxford.
The British Health Regulatory Authority (MHRA) gave the “green light”, noting that it was now safe for testing to continue, the company announced on Saturday.
It is recalled that on Tuesday the company had announced the suspension of tests, as one of the participating volunteers showed a side effect.
As indicated in the announcement issued by the company: “AstraZeneca and the University of Oxford, as test sponsors, are unable to disclose further medical information but, according to the competent authorities, AstraZeneca is committed to the safety of examinees based on the highest standards.” “The company will continue to work with health authorities around the world to guide when other clinical trials can be resumed to deliver the vaccine widely, fairly and cost-effectively during this pandemic.”
The possible vaccine under the name AZD1222 was invented by the University of Oxford and the company, Vaccitech, continues the same announcement. “It uses a chimpanzee viral vector based on an attenuated version of a common cold virus (adenovirus) and contains the genetic material of the SARS-CoV-2 virus protein.” After vaccination, the protein that activates the virus is produced immune system to attack the SARS-CoV-2 virus. “
